{"id":5066,"date":"2022-06-21T13:08:56","date_gmt":"2022-06-21T11:08:56","guid":{"rendered":"https:\/\/www.pharmaforum.be\/?p=5066"},"modified":"2022-07-26T09:45:37","modified_gmt":"2022-07-26T07:45:37","slug":"taux-de-tva-a-6-sur-masques-et-gha","status":"publish","type":"post","link":"https:\/\/www.pharmaforum.be\/fr\/taux-de-tva-a-6-sur-masques-et-gha\/","title":{"rendered":"TAUX DE TVA \u00c0 6% SUR MASQUES ET GHA \u2013 PROLONGATION."},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"5066\" class=\"elementor elementor-5066\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-aaadf50 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"aaadf50\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-6fce739\" data-id=\"6fce739\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-fbd7b49 elementor-widget elementor-widget-text-editor\" data-id=\"fbd7b49\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h2>Maintien du taux de TVA \u00e0 6% sur les masques et gels hydroalcooliques jusqu&#8217;au 30 juin 2022.<\/h2><p>Sur proposition du ministre des Finances Vincent Van Peteghem, le Conseil des ministres a approuv\u00e9 un projet d\u2019arr\u00eat\u00e9 royal relatif \u00e0 la prolongation temporaire du taux r\u00e9duit de la TVA de 6 % sur les masques buccaux et les gels hydroalcooliques.<\/p><p>Cette prolongation vise \u00e0 assurer une continuit\u00e9 dans l\u2019application de ce taux r\u00e9duit de la TVA pour ces biens. Cette mesure contribue au soutien financier des citoyens relatif aux biens de protection n\u00e9cessaires \u00e0 la pr\u00e9vention de la propagation du Covid-19. La prolongation temporaire couvre la p\u00e9riode du 1er avril au 30 juin 2022 inclus.<\/p><p>Le projet est soumis \u00e0 la signature du Roi.<\/p><p><em>Projet d\u2019arr\u00eat\u00e9 royal modifiant l&#8217;arr\u00eat\u00e9 royal n\u00b020, du 20 juillet 1970, fixant les taux de la taxe sur la valeur ajout\u00e9e et d\u00e9terminant la r\u00e9partition des biens et des services selon ces taux en ce qui concerne les masques buccaux et les gels hydroalcooliques.<\/em><\/p><p>\u00a9 <a href=\"https:\/\/news.belgium.be\/fr\/covid-19-prolongation-du-taux-reduit-de-la-tva-sur-les-masques-buccaux-et-les-gels-hydroalcooliques\">news.belgium<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Maintien du taux de TVA \u00e0 6% sur les masques et gels hydroalcooliques jusqu&#8217;au 30 juin 2022.<\/p>\n","protected":false},"author":933,"featured_media":5252,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"none","_seopress_titles_title":"Taux de TVA \u00e0 6% sur masques et GHA - Pharma forum","_seopress_titles_desc":"Maintien du taux de TVA \u00e0 6% sur les masques et gels hydroalcooliques jusqu&#039;au 30 juin 2022.","_seopress_robots_index":"","footnotes":""},"categories":[391,15],"tags":[],"edition":[],"class_list":["post-5066","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infos-generales","category-pharmaforum"],"_links":{"self":[{"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/posts\/5066","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/users\/933"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/comments?post=5066"}],"version-history":[{"count":5,"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/posts\/5066\/revisions"}],"predecessor-version":[{"id":7067,"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/posts\/5066\/revisions\/7067"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/media\/5252"}],"wp:attachment":[{"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/media?parent=5066"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/categories?post=5066"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/tags?post=5066"},{"taxonomy":"edition","embeddable":true,"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/edition?post=5066"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}